Drugs / Econazole Nitrate
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | SPECTAZOLE | — | 1982-12-23 | fda.gov ↗ |
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT00768599 | Mar → Sep 2008 | tinea pedis | AmDerma | Completed | No outcome recorded |
| Phase 32 trials | ||||||
| Phase 3 | NCT01358240 | Jun 2011 → Apr 2012 | tinea pedis | AmDerma | Completed | No outcome recorded |
| Phase 3 | NCT01353976 | May 2011 → Apr 2012 | tinea pedis | AmDerma | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Econazole Nitrate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01358240 ↗ |
| Route | Topical | “Topical cream, applied once daily for 4 weeks.” NCT00768599 ↗ |